Clinical Trial: Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739628) titled 'Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans' on July 22.

Brief Summary: The goal of this clinical trial is to test if an artificial intelligence (AI) tool called DeepBMD can accurately identify people at high risk for osteoporosis using routine chest or abdomen CT scans. The main questions it aims to answer are:

1. Can the DeepBMD tool correctly identify people who have osteoporosis compared to the standard bone density test, dual-energy X-ray absorptiometry (DXA)?

2. Is it practical to use this AI tool in real-world hospital settings to find and contact high-risk ...